1.Boyce, IM, Potter-Bynoe, G, Dziobek, L, Solomon, SL. Nosocomial pneumonia in Medicare patients: hospital costs and reimbursement patterns under the prospective payment system. Arch Intern Med 1991;151:1109–1114.
2.Haley, RW, Culver, DH, White, JW, Morgan, WM, Emori, TG. The nationwide nosocomial infection rate: a new need for vital statistics. Am J Epidemiol 1985;121:159–167.
3.larvis, WR. Selected aspects of the socioeconomic impact of nosocomial infections: morbidity, mortality, cost, and prevention. Infect Control Hosp Epidemiol 1996;17:552–557.
4.Burke, JP. Infection control: a problem for patient safety. N Engl J Med 2003;348:651–656.
5.larvis, WR. The state of the science of health care epidemiology, infection control, and patient safety, 2004. Am J Infect Control 2004;32:496–503.
6.Institute for Healthcare Improvement. WOK Lives Campaign: Some Is Not a Number, Soon Is Not a Time. Cambridge, MA: Institute for Healthcare Improvement; 2006.
7.Joint Commission on Accreditation of Healthcare Organizations. Joint Commission Standards. Oakbrook Terrace, IL: Joint Commission on Accreditation of Healthcare Organizations; 2006.
8.Fraser, VJ. Starting to learn about the costs of nosocomial infections in the new millennium: where do we go from here? Infect Control Hosp Epidemiol 2002;23:174–176.
9.Lauria, FN, Angeletti, C. The impact of nosocomial infections on hospital care costs. Infection 2003;31(suppl 2):35–43.
10.Baker, AM, Meredith, JW, Haponik, EF. Pneumonia in intubated trauma patients: microbiology and outcomes. Am J Respir Crit Care Med 1996;153:343–349.
11.Relio, J, Ollendorf, DA, Oster, G, et al.Epidemiology and outcomes of ventilator-associated pneumonia in a large US database. Chest 2002;122:2115–2121.
12.Haley, RW. Measuring the costs of nosocomial infections: methods for estimating economic burden on the hospital. Am f Med 1991;9L32S–38S.
15.Kaye, KS, Engemann, JJ, Fulmer, EM, Clark, CC, Noga, EM, Sexton, DJ. Favorable impact of an infection control network on nosocomial infection rates in community hospitals. Infect Control Hosp Epidemiol 2006;27:228–232.
16.Garner, JS, Jarvis, WR, Emori, TG, Horan, TC, Hughes, JM. CDC definitions for nosocomial infections, 1988. Am J Infect Control 1988;16:128–140.
17.Apisarnthanarak, A, Jones, M, Waterman, BM, Carroll, CM, Bernardi, R, Fraser, VJ. Risk factors for spinal surgicalsite infections in a community hospital: a case-control study. Infect Control Hosp Epidemiol 2003;24:31–36.
18.Boyce, JM, Potter-Bynoe, G, Dziobek, L. Hospital reimbursement patterns among patients with surgical wound infections following open heart surgery. Infect Control Hosp Epidemiol 1990;11:89–93.
19.Coello, R, Glenister, H, Fereres, J, et al.The cost of infection in surgical patients: a case-control study. J Hosp Infect 1993;25:239–250.
20.Hollenbeak, CS, Murphy, DM, Koenig, S, Woodward, RS, Dunagan, WC, Fraser, VJ. The clinical and economic impact of deep chest surgical site infections following coronary artery bypass graft surgery. Chest 2000;118:397–402.
21.Kirkland, KB, Briggs, JP, Trivette, SL, Wilkinson, WE, Sexton, DJ. The impact of surgical-site infections in the 1990s: attributable mortality, excess length of hospitalization, and extra costs. Infect Control Hosp Epidemiol 1999;20:725–730.
22.VandenBergh, MF, Kluytmans, JA, van Hout, BA, et al.Cost-effectiveness of perioperative mupirocin nasal ointment in cardiothoracic surgery. Infect Control Hosp Epidemiol 1996;17:786–792.
23.Vegas, AA, Jodra, VM, Garcia, ML. Nosocomial infection in surgery wards: a controlled study of increased duration of hospital stays and direct cost of hospitalization. Eur J Epidemiol 1993;9:504–510.
24.Whitehouse, JD, Friedman, ND, Kirkland, KB, Richardson, WJ, Sexton, DJ. The impact of surgical-site infections following orthopedic surgery at a community hospital and a university hospital: adverse quality of life, excess length of stay, and extra cost. Infect Control Hosp Epidemiol 2002;23:183–189.
25.Hugonnet, S, Eggimann, P, Borst, F, Maricot, P, Chevrolet, JC, Pittet, D. Impact of ventilator-associated pneumonia on resource utilization and patient outcome. Infect Control Hosp Epidemiol 2004;25:1090–1096.
26.Kappstein, I, Schulgen, G, Beyer, U, Geiger, K, Schumacher, M, Daschner, FD. Prolongation of hospital stay and extra costs due to ventilator-associated pneumonia in an intensive care unit. Eur J Clin Microbiol Infect Dis 1992;11:504–508.
27.Papazian, L, Bregeon, F, Thirion, X, et al.Effect of ventilator-associated pneumonia on mortality and morbidity. Am J Respir Crit Care Med 1996;154:91–97.
28.Warren, DK, Shukla, SJ, Olsen, MA, et al.Outcome and attributable cost of ventilator-associated pneumonia among intensive care unit patients in a suburban medical center. Crit Care Med 2003;31:1312–1317.
29.Chen, YY, Chou, YC, Chou, P. Impact of nosocomial infection on cost of illness and length of stay in intensive care units. Infect Control Hosp Epidemiol 2005;26:281–287.
30.Digiovine, B, Chenoweth, C, Watts, C, Higgins, M. The attributable mortality and costs of primary nosocomial bloodstream infections in the intensive care unit. Am J Respir Crit Care Med 1999;160:976–981.
31.Orsi, GB, Di Stefano, L, Noah, N. Hospital-acquired, laboratory-confirmed bloodstream infection: increased hospital stay and direct costs. Infect Control Hosp Epidemiol 2002;23:190–197.
32.Pirson, M, Dramaix, M, Straelens, M, Riley, TV, Leclercq, P. Costs associated with hospital-acquired bacteraemia in a Belgian hospital. J Hosp Infect 2005;59:33–40.
33.Pittet, D, Tarara, D, Wenzel, RP. Nosocomial bloodstream infection in critically ill patients: excess length of stay, extra costs, and attributable mortality. JAMA 1994;271:1598–1601.
34.Moris de la Tassa, J, Fernandez Munoz, P, Antuna Egocheaga, A, Gutierrez del Rio, MC, Carton Sanchez, JA. Estimating the costs associated with nosocomial urinary tract infection: a case-control study. Revista Clinica Espanola 2003;203:119–124.
35.Wenzel, RP. The Lowbury Lecture: the economics of nosocomial infections. J Hosp Infect 1995;31:79–87.
36.Graves, N. Economics and preventing hospital-acquired infection. Emerg Infect Dis 2004;10:561–566.
37.Stone, PW, Larson, E, Kawar, LN. A systematic audit of economic evidence linking nosocomial infections and infection control interventions: 1990-2000. Am J Infect Control 2002;30:145–152.
38.Medicare program; prospective payment system for long-term care hospitals RY 2007: annual payment rate updates, policy changes, and clarification: final rule. Federal Register 2006;71:27797–27939.
39.Revised ICD-9-CMDRG Definitions Manual, Version 18.0. 18th ed. Murray, UT: 3M Health Information Systems; 2002.
40.Farber, BF. Reimbursement for nosocomial infections under the prospective payment plan: the future or decline of infection control? Infect Control 1984;5:425–426.
41.Boyce, JM, Dziobek, L, Potter-Bynoe, G. Reimbursement for nosocomial infections. Ann Intern Med 1988;108:776.
42.Haley, RW, White, JW, Culver, DH, Hughes, JM. The financial incentive for hospitals to prevent nosocomial infections under the prospective payment system: an empirical determination from a nationally representative sample. JAMA 1987;257:1611–1614.
43.Haley, RW, Culver, DH, White, JW, et al.The efficacy of infection surveillance and control programs in preventing nosocomial infections in US hospitals. Am J Epidemiol 1985;121:182–205.
44.Reduction in central line-associated bloodstream infections among patients in intensive care units: Pennsylvania, April 2001-March 2005. MMWR Morb Mortal Wkly Rep 2005;54:1013–1016.
45.Babcock, HM, Zack, JE, Garrison, T, et al.An educational intervention to reduce ventilator-associated pneumonia in an integrated health system: a comparison of effects. Chest 2004;125:2224–2231.
46.Wakefield, DS, Pfaller, MA, Hammons, GT, Massanari, RM. Use of the appropriateness evaluation protocol for estimating the incremental costs associated with nosocomial infections. Med Care 1987;25:481–488.